SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0720+2.9%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Howard Williams8/28/2014 2:35:32 PM
   of 13111
 
Sinopharm Starts Talks With Provectus Over Anticancer

Thursday August 28, 2014

An article appearing in PharmAsia News reports that Sinopharm A-Think and Sinopharm-China State Institute of Pharmaceutical Industry, as part of Sinopharm's planned expansion in the China oncology sector, has signed a memorandum of Understanding (MoU) with Provectus to begin talks on PV-10 licensing.

A reprint of the article in PDF format is available from the Provectus website at
http://www.pvct.com/news/PAN_28140824005_webpost.pdf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext